ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
TRIM69 alleviates ultraviolet B irradiation-induced ferroptosis by regulating p53 in human lens epithelial cells.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeAge-related cataract (ARC) is the leading cause of visual impairment worldwide, with ultraviolet B (UVB) radiation recognized as a major risk factor. This study aimed to investigate whether UVB induces ferroptosis in human lens epithelial cells (HLECs) and to explore the role of TRIM69 in modulating this process through the p53 signaling pathway.
methodsHLECs were exposed to UVB irradiation, and ferroptosis was assessed by measuring cell viability, reactive oxygen species (ROS) accumulation, glutathione peroxidase 4 (GPX4) expression, and glutathione (GSH) levels. Ferroptosis inhibition was examined using ferrostatin-1 (Fer-1). TRIM69 expression was modulated by overexpression and knockdown, while the interaction with p53 signaling was evaluated through p53 overexpression assays. Western blotting was performed to analyze GPX4 and SLC7A11 expression.
resultsUVB exposure induced ferroptosis in HLECs, evidenced by reduced GPX4 and GSH, elevated ROS, and decreased viability. Fer-1 treatment significantly improved cell viability and suppressed ROS accumulation. TRIM69 overexpression significantly mitigated the effects of UVB irradiation on cell viability, GSH levels and ROS production, whereas knocking down TRIM69 expression exacerbated these effects. Importantly, p53 overexpression reversed the protective effects of TRIM69 and downregulated GPX4 and SLC7A11, implicating p53-dependent signaling in ferroptosis regulation.
conclusionThese findings demonstrate that TRIM69 protects HLECs against UVB-induced ferroptosis by inhibiting p53-mediated suppression of GPX4 and SLC7A11. TRIM69 may represent a promising therapeutic target for preventing oxidative damage and delaying the onset of ARC.
Indexed as
Identifiers
41369736What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.